CLINICAL-FEATURES AND OUTCOME OF 80 PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:0
|
作者
GABRIELLI, A [1 ]
CORVETTA, A [1 ]
MONTRONI, M [1 ]
RICCIATTI, AM [1 ]
NITTI, C [1 ]
DANIELI, MG [1 ]
DANIELI, G [1 ]
机构
[1] UNIV ANCONA,IST CLIN MED,I-60100 ANCONA,ITALY
来源
JOURNAL OF IMMUNOLOGICAL RESEARCH | 1991年 / 3卷 / 04期
关键词
MORBIDITY; MORTALITY; SYSTEMIC LUPUS ERYTHEMATOSUS;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The spectrum of organ involvement and outcome of 80 patients with Systemic Lupus Erythematosus (SLE) have been assessed in a retrospective study. Joint manifestations and constitutional symptoms were the most common features. Nephritis was present in 16 patients at disease onset and developed in further 21 during the course of their disease. Patients with late-onset SLE (after age 50; 33.3%) had a lower incidence of renal disease similar to that found in patients younger than 20 years (26.3%). The mean interval from onset of first symptoms to diagnosis was shorter in patients evaluated from 1984 to 1989: 7.2 months versus 24.9 months of the patients first seen in the previous six years. Eight deaths occurred (10%) and lupus-related organ or system involvement (mainly CNS and active nephritis) were the most frequent primary causes of death. Two of the patients who died of cerebrovascular disease had high anticardiolipin antibodies and in a third the level was borderline. This finding implies that antiphospholipid immunity may be an important contributing cause of death and underscores the urgency of an appropriate treatment of this abnormality.
引用
收藏
页码:175 / 179
页数:5
相关论文
共 50 条
  • [1] CLINICAL-FEATURES AND OUTCOME OF INFECTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    KIERNAN, M
    BRESNIHAN, B
    IRISH JOURNAL OF MEDICAL SCIENCE, 1983, 152 (10) : 382 - 386
  • [2] CLINICAL-FEATURES OF PATIENTS WITH MILD SYSTEMIC LUPUS-ERYTHEMATOSUS
    YAMANE, K
    SHOME, GP
    AKAMA, T
    SUZUKI, H
    MATSUI, Y
    KASHIWAGI, H
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1991, 20 (06) : 397 - 405
  • [3] CLINICAL-FEATURES OF EARLY CASES OF SYSTEMIC LUPUS-ERYTHEMATOSUS IN IRAQI PATIENTS
    ALRAWI, Z
    ALSHAARBAF, H
    ALRAHEEM, E
    KHALIFA, SJ
    BRITISH JOURNAL OF RHEUMATOLOGY, 1983, 22 (03): : 165 - 171
  • [4] SYSTEMIC LUPUS-ERYTHEMATOSUS IN GREECE - CLINICAL-FEATURES, EVOLUTION AND OUTCOME - A DESCRIPTIVE ANALYSIS OF 292 PATIENTS
    VLACHOYIANNOPOULOS, PG
    KARASSA, FB
    KARAKOSTAS, KX
    DROSOS, AA
    MOUTSOPOULOS, HM
    LUPUS, 1993, 2 (05) : 303 - 312
  • [5] SLE (SYSTEMIC LUPUS-ERYTHEMATOSUS) - RELATED CLINICAL-FEATURES IN THE DOG
    GOUDSWAARD, J
    SCHELL, WER
    VANTOOR, AJ
    CRAMA, K
    TIJDSCHRIFT VOOR DIERGENEESKUNDE, 1993, 118 (06) : 185 - 189
  • [6] CHANGING PATTERN OF CLINICAL-FEATURES AND PROGNOSIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    HASHIMOTO, H
    SHIOKAWA, Y
    JOURNAL OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE, 1981, 70 (03): : 393 - 399
  • [7] LABORATORY AND CLINICAL-FEATURES IN SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS WITH OR WITHOUT ANTICARDIOLIPIN ANTIBODIES
    VOGEL, JJ
    REBER, G
    DEMOERLOOSE, P
    THROMBOSIS RESEARCH, 1991, 62 (05) : 545 - 556
  • [8] CLINICAL-FEATURES OF SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS WITH ANTI-HISTONE ANTIBODIES
    FRITZLER, M
    RYAN, P
    KINSELLA, TD
    JOURNAL OF RHEUMATOLOGY, 1982, 9 (01) : 46 - 51
  • [9] COMPARATIVE CLINICAL-FEATURES IN PATIENTS WITH MYASTHENIA-GRAVIS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    CHAN, MKL
    BRITTON, M
    JOURNAL OF RHEUMATOLOGY, 1980, 7 (06) : 838 - 842
  • [10] ANTINUCLEAR ANTIBODIES ASSOCIATION WITH SELECT CLINICAL-FEATURES IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    TREADWELL, EL
    SWANSON, ML
    WILLIAMS, DD
    NEWTON, JL
    ARTHRITIS AND RHEUMATISM, 1994, 37 (06): : R23 - R23